NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Aug 9, 2024 424B5
10-Q May 15, 2024 10-Q
UPLOAD May 13, 2024
CORRESP May 8, 2024
UPLOAD Apr 22, 2024
CORRESP Apr 9, 2024
8-K Apr 5, 2024 FORM 8-K
424B5 Apr 5, 2024 424B5
8-K Feb 16, 2024 FORM 8-K
10-Q Feb 14, 2024 10-Q
UPLOAD Feb 13, 2024
8-K Jan 19, 2024 FORM 8-K
DEF 14A Dec 4, 2023 DEF 14A
10-Q Nov 14, 2023 10-Q
8-K Nov 7, 2023 FORM 8-K
10-K Oct 13, 2023 10-K
NT 10-K Sep 28, 2023 NT 10-K
8-K Sep 1, 2023 FORM 8-K
424B5 Aug 7, 2023 424B5
8-K May 25, 2023 FORM 8-K
EFFECT May 22, 2023
CORRESP May 17, 2023
10-Q May 15, 2023 10-Q
UPLOAD May 12, 2023
S-3/A May 8, 2023 FORM S-3/A
← Newer Page 3 of 23 · 556 filings Older →